Company News

Share this article:

Sepracor moved creative duties for Lunesta from The Kaplan Thaler Group, a New York-based Publicis shop, to Lowe, an IPG shop, Adweek reported. Prior to The Kaplan Thaler Group, the creative account was handled by IPG's McCann HumanCare.

Bioniche Pharma, a manufacturer of specialty injectables, received a warning letter from DDMAC regarding web pages for Sotradecol (sodium tetradecyl sulfate injection) located on the Bioniche and AngioDynamics websites. The pages “fail to communicate any information about the risks associated with the product,” the letter stated. Bioniche was cited for the same violations in April of 2006. Sotradecol is indicated in the treatment of small, uncomplicated varicose veins.


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Miss Idaho shows off diabetes pump

NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."

Roche is hungry, not starving for M&A

CEO Severin Schwan tells Reuters that the Swiss firm will be looking for small acquisitions and partnerships.

AbbVie nabs Shire for $54B

AbbVie, in the latest example of a US drugmaker seeking to lower its tax rate, said today that it's buying Dublin-based Shire for $54 billion.